Cyclic nucleotide phosphodiesterase

3',5'-cyclic nucleotide phosphodiesterase
Phosphodiesterase 4D hexamer, Human
Identifiers
SymbolPDEase_I
PfamPF00233
InterProIPR002073
PROSITEPDOC00116
SCOP21f0j / SCOPe / SUPFAM
CDDcd00077
Available protein structures:
Pfam  structures / ECOD  
PDBRCSB PDB; PDBe; PDBj
PDBsumstructure summary
3′,5′-cyclic-nucleotide phosphodiesterase
Identifiers
EC no.3.1.4.17
CAS no.9040-59-9
Databases
IntEnzIntEnz view
BRENDABRENDA entry
ExPASyNiceZyme view
KEGGKEGG entry
MetaCycmetabolic pathway
PRIAMprofile
PDB structuresRCSB PDB PDBe PDBsum
Gene OntologyAmiGO / QuickGO
Search
PMCarticles
PubMedarticles
NCBIproteins

3′,5′-cyclic-nucleotide phosphodiesterases (EC 3.1.4.17) are a family of phosphodiesterases. Generally, these enzymes hydrolyze a nucleoside 3′,5′-cyclic phosphate to a nucleoside 5′-phosphate:

nucleoside 3′,5′-cyclic phosphate + H2O = nucleoside 5′-phosphate

They thus control the cellular levels of the cyclic second messengers and the rates of their degradation.[1] Some examples of nucleoside 3′,5′-cyclic phosphate include:

There are 11 distinct phosphodiesterase families (PDE1–PDE11) with a variety in isoforms and splicing having unique three-dimensional structure, kinetic properties, modes of regulation, intracellular localization, cellular expression, and inhibitor sensitivities.[1]

  1. ^ a b Bender AT, Beavo JA (September 2006). "Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use". Pharmacological Reviews. 58 (3): 488–520. doi:10.1124/pr.58.3.5. PMID 16968949. S2CID 7397281.